Bacil Pharma Ltd — Updates, 14-08-2025: Company Update

Bacil Pharma Limited has announced that its statutory auditor, M/s Laxmikant Kabra & Co LLP, has resigned. The auditor was appointed in September 2022 and was scheduled to serve until the 35th Annual General Meeting in 2027. They had submitted audit reports for the year ended March 2025 and a limited review report for the quarter ended June 2025. The company stated that the detailed reasons for the resignation are in the attached letter, but no concerns were raised by the auditor in this disclosure. This change impacts financial oversight and transparency for shareholders.